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Abstract
The progression of Alzheimer’s disease (AD) is correlated to
the degenerative activation of muscarinic acetylcholine
receptors (mAChR) located in the brain. They are a family of
five G-protein coupled receptors, (M1-M5), linked to have
functions within the central and peripheral nervous system.1
More specifically, activation of an M1 receptor with positive
allosteric modulators (PAM), have shown to bind to the
allosteric pocket and slow the degenerative process of AD with
minimal intrinsic effects.2 Structural motifs of potent PAM
activity and weak agonism proposed a synthesis of an
isooxazoline compound, incorporating a 1,3-dipolar
cycloaddition. The core motif of the proposed isooxazoline
structure has been created and further synthesis of the
pendant and top is required.

Methodology
The creation of the proposed
isooxazoline core motif occurs in
two phases. The first phase
synthesized cinnamaldehyde oxime
by adding 20 mmol of
cinnamaldehyde into a solution of 5
mL of H2O, 5 mL ethanol, and 10 mL of ice. Added to this
solution was 40 mmol of a 50% aqueous solution of NaOH and
stirred for 18 hours at room
temperature. The oxime was
then extracted from the
organic phase while the aqueous phase was acidified to pH 5
from HCl and was extracted once more.

The second phase formed the ring through 1,3-dipolar
cycloaddition which is the core motif. This was synthesized by
adding oxime with 2.79 mL of triethylamine and 1.864 g of
cyanuric chloride in an ice bath for 15 minutes to create the
nitrile. The oxide was then removed from the ice bath and left
under constant agitation for 30 minutes with 20 mL of diethyl
ether and extracted by gravity filtration. The oxide and 1.421 g of
acrylamide was added and stirred for 24 hours. Mass
spectrometer (MS) was used to analyze both phases while thin
layer chromatography (TLC) and nuclear magnetic resonance
(NMR) was used on the second phase.

Results

Figure A is the chromatogram of phase 1 in representative of the
molecule of interest, cinnamaldehyde oxime, with the
breakdown of the molecule on figure B. Figure B represents the
shows multiple peaks at that 13.187 minutes, Figure A. There is
a peak at 148.1 m/z and two large peaks at 130.0 m/z and 77.0
m/z.

Figure C and E represents analysis for phase 2 for synthesizing the
isooxazoline core motif. Figure D shows the mass spectroscopy
data of the core motif breakdown at 11.641 minutes as seen on
figure C. There are peaks at 129.o m/z, 102.o m/z, and 76.0 m/z
that represents different parts of the molecule when being broken
down.
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Discussion
We are interested in synthesizing a potential PAM-agonist
with minimal intrinsic effects by using isooxazoline
characteristic structure. The synthesis of isooxazoline through
1,3-dipolar cycloaddition with the purpose of being used as a
potential PAM agonist with minimal intrinsic effects. The
product from phase two is an electron rich dipole which allows
its highest occupied molecular orbital (HOMO) to interact
with the lowest unoccupied molecular orbital (LUMO) of a
dipolarphile. This phase formed the ring which is
characteristic of isooxazoline core motif. Analysis from figure
A shows a peak at 148.1 m/z which shows the protonated
version of the oxime of interest that has a molecular ion of
147.17. Correspondingly, 77.0 m/z is similar to that of a
deprotonated benzene ring which has a molecular ion of 78.11
Analysis of MS from figure B showed that the compound of
interest have been created. Phase two created the dipole,
nitrile oxide, to be able to interact with the dipolarphile,
acrylamide, through 1,3-dipolar cycloaddition. Analysis of TLC
(not shown) showed unconvincing data that the core motif has
been created. But, through the use of MS, there seems to be
more convincing data. Figure D shows the benzene peak at
76.0 m/z. There is a styrene peak at 102.0 m/z which could be
shown from the breakdown of the molecule. The peak at 129.0
m/z is the other half from the styrene which includes the
carboxamide, isoxazole, and a methyl that has a total
molecular ion of 128.13. Future research requires synthesizing
the top and pendent motif for which it can be attached to the
core to fully create the proposed isooxazoline structure.
Looking further down the line, the proposed structure can be
tested as a PAM-agonist compound hopefully with minimal
intrinsic effects to test against Alzheimer’s disease.
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